Insights & Analysis
Practical guidance on PBM audits, federal investigations, compounding defense, DEA enforcement, telehealth compliance, and the regulatory pressures facing pharmacies and providers nationwide.
More articles — Page 44
Page 44 of 114 · 1029 articles
Whistleblower Retaliation Claims by Former Employees
Protected activity, the three elements of a Section 3730(h) retaliation claim, and how a defensible termination record built in ad…
When an Employee Threatens to Report You
Preservation steps, False Claims Act retaliation exposure, and the personnel decisions that need counsel review before a report be…
Molecular Laboratories Increasingly Turn to Health Law Alliance for Assistance with CPT Code 87798 Level 3 Denials, Payment Suspensions, and UPIC Audits
Leading healthcare law firm employs former Medicare and UPIC investigators, attorney-clinicians, federal and state prosecutors, an…
Wound Care Practices Facing Prepayment Review
How wound care practices manage the cash-flow hit of Medicare prepayment review and what actually meets the error-rate criteria th…
Wound Care Telehealth and Remote Assessment Limits
What Medicare covers for wound care telehealth, why debridement stays in-person, and how hybrid practices should document each vis…
Responding to a Board of Pharmacy Complaint
What a board of pharmacy complaint notice starts, what a written response should confirm or leave out, and how early statements ca…
Telehealth and the Anti-Kickback Statute
Referral fees, marketing arrangements, and the safe harbor analysis telehealth companies need before the Anti-Kickback Statute bec…
Waivers of OIG Exclusion for Sole Community Providers
The narrow path to waiving an OIG program exclusion: the sole community physician standard, who can request it, and what it does n…
Telehealth Companies and the Corporate Practice of Medicine
Friendly PC and MSO structures, fee-splitting limits, and the 2025-2026 state enforcement wave telehealth companies now face over…